In a Liv Hospital study, stem cell therapy improved heart function dramatically using MSCs and EVs, despite a blocked graft.

A new study suggests that dementia may be driven in part by faulty blood flow in the brain. Researchers found that losing a ...

Despite a Trump administration push, there are few facilities offering the complex treatment in the rural areas where many ...

Researchers have developed a novel "theragnostic" approach for ischemic stroke using extracellular vesicles derived from human exfoliated deciduous teeth stem cells (SHED-EVs). Engineered with quantum ...

Studies show a partial-match bone marrow transplant is rewriting the future for sickle cell patients, with survival rates ...

Signs of heart disease in women differ from the classic chest pain seen in men. Spotting these signs can help you get better ...

Despite decades of research, the average life expectancy for an American with sickle cell remains about 20 years shorter than ...

Wearables are making blood pressure an easier and more appealing metric to pay attention to. And docs say attention to BP is ...

Stripe patterns are commonly seen in nature—for instance, birds and fish move in coordinated flocks and schools, fingerprints ...

An announcement from Hemostemix ( ($TSE:HEM) ) is now available. Hemostemix has raised C$480,000 through a non-brokered private placement of ...

No one's crossed the finishing line yet, but drug developer Nyrada is leading the Great Biotech Regatta of 2025 with close to ...

The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.